Silo Wellness Inc.

SILO

CA8271242072

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 03:44:08 2023-08-28 pm EDT			5-day change	1st Jan Change
0.01 ^CAD	+100.00%		-.--%	-.--%

2023	Silo Wellness Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	CI
2023	Silo Wellness Inc. announced that it expects to receive CAD 2 million in funding	CI

Silo Wellness Inc. Announces Resignation of Gerard Lee from as A Director of the Board

February 17, 2023 at 08:04 am EST

Silo Wellness Inc. accepted the resignation of Gerard Lee from his position as a director of the board, effective immediately. The board of directors includes Greg Biniowsky (independent director), Vancouver lawyer; Simon Bababeygy, M.D. (independent director), California physician; Michael Hartman, California pharmaceutical chemist; and Mike Arnold, Oregon lawyer.

Latest news about Silo Wellness Inc.

Silo Wellness Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-29	CI
Silo Wellness Inc. announced that it expects to receive CAD 2 million in funding	23-08-28	CI
Silo Wellness Inc. enter into a letter of intent to acquire NUGL Inc. for CAD 40.2 million.	23-08-28	CI
Kaya Group Forges Partnership with Silo Wellness for Psychedelic Wellness Experiences and Retreats	23-08-03	CI
Silo Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-28	CI
Silo Wellness Inc. Auditor Raises 'Going Concern' Doubt	23-04-04	CI
Silo Wellness Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	23-04-04	CI
Silo Wellness Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	23-04-04	CI
Michael Hartman entered into a definitive stock purchase agreement to acquire SW Holdings, Inc. from Silo Wellness Inc. for CAD 0.21 million.	23-03-27	CI
Silo Wellness Inc. Announces Resignation of Gerard Lee from as A Director of the Board	23-02-17	CI
Silo Wellness Inc. Executes Binding Term Sheet for A Joint Venture with New Frontier Ranch	22-10-20	CI
Silo Wellness Inc. completed the acquisition of Dyscovry Science Ltd.	22-10-16	CI
Silo Wellness Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	22-09-28	CI
384,082 Common Shares of Yukoterre Resources Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2022.	22-09-23	CI
Silo Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	22-06-29	CI
Silo Wellness Inc. Announces Change of Chief Executive Officer	22-06-09	CI
Silo Wellness Inc. executed a nonbinding letter of intent to acquire Dyscovry Science Ltd.	22-05-30	CI
Silo Wellness Inc. announced that it expects to receive CAD 5.95 million in funding from Alpha Blue Ocean Investment Group	22-04-13	CI
Silo Wellness Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022	22-03-30	CI
384,081 Common Shares of Yukoterre Resources Inc. are subject to a Lock-Up Agreement Ending on 24-MAR-2022.	22-03-23	CI
Silo Wellness Inc. Reports Earnings Results for the Full Year Ended October 31, 2021	22-03-02	CI
Silo Wellness Inc. Auditor Raises 'Going Concern' Doubt	22-03-01	CI
Silo Wellness Inc. announced that it expects to receive $0.494988 million in funding from Orthogonal Thinker, Inc., Investment Arm	22-02-02	CI
Silo Wellness Signs Distribution Deal with Flawless CBD for Functional Mushroom Products	22-02-02	CI
Silo Wellness Inc. Announces Board Changes	22-01-06	CI

Chart Silo Wellness Inc.

Duration

Period

More charts

Company Profile

Silo Wellness, Inc. is a Canada-based global psychedelics company. The Company is engaged in psilocybin wellness retreats. The Company operates through the Jamaica retreats segment. The Company offers psychedelic wellness retreats in Jamaica and is focused on doing the same in Oregon, United States. The Company also maintains rights in intellectual property (IP). In addition to its IP portfolio, The Company is focusing on consumer product and wellness retreat brand development for psychedelics. It is focusing on improving health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance, by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion.

Sector

Pharmaceuticals

Calendar

2024-09-25 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SILO WELLNESS INC.	-.--%	1.13M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+26.46%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+14.70%	231B
NOVARTIS AG	+5.04%	200B
ROCHE HOLDING AG	-8.96%	195B
AMGEN INC.	-6.26%	145B